Da hab ich die Teile fast 7 Monate im Depot, den Finger am Abzug weil Sepracor aus
dem Nasi 100 fliegt und was passiert?
Tagessieg im Nasi 100 Index wegen guter News.
As for Sepracor, the Marlborough, Mass.-based company said that it plans to submit by mid-February an application to market its drug, called Estorra, as a treatment for "transient and chronic" sleeplessness.
The company said it made its decision following "recent discussions" with FDA officials.
Sepracor was once a highflier as investors had big hopes for the company's strategy of developing enhanced versions of already available prescription drugs.
But the company suffered a major setback in March, when the FDA rejected Sepracor's much-anticipated anti-allergy drug.
Sepracor's stock plunged 60 percent in the immediate aftermath of the regulatory setback.
In its statement Thursday, Sepracor cautioned that "there can be no assurance" that the FDA will approve the application to market Estorra.
Ted Griffith is a reporter for CBS.MarketWatch.com
Seltsam, aber mir solls recht sein.